Rare diseases - Xconomy

Entry	Author	Date	Location
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug	Arlene Weintraub	05/23/12	Boston
Pfizer Takes on Genzyme With New Gaucher Drug	Arlene Weintraub	05/02/12	Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup	Arlene Weintraub	04/03/12	New York
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments	Arlene Weintraub	01/11/12	New York
Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher	Luke Timmerman	10/24/11	Boston
Synageva to Merge With Trimeris	Erin Kutz	06/13/11	Boston
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit	Arlene Weintraub	05/12/11	New York
Zacharon Nabs $210M Deal With Pfizer to Tackle Orphan Diseases	Luke Timmerman	04/07/11	San Diego
Synageva Grabs $25M for Rare Diseases Drug Pipeline	Ryan McBride	03/21/11	Boston
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests	Ryan McBride	03/15/11	Boston
Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal	Ryan McBride	03/08/11	Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche	Ryan McBride	03/03/11	Boston
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders	Gregory T. Huang	03/01/11	Boston
Genzyme Rival Fails to Get FDA Approval	Ryan McBride	02/25/11	Boston
Alexion Pharma Gobbles Up Taligen in $111M Buyout	Ryan McBride	01/31/11	Boston
Genzyme to Let Diagnostics Unit Loose for $265M	Ryan McBride	11/18/10	Boston
PerkinElmer Expects to Make Acquisitions After $500M Business Sale: CEO Talks Boston-Area Talent and Growth in Software, Imaging	Ryan McBride	09/13/10	Boston
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News	Erin Kutz	09/08/10	Boston
PerkinElmer Sells Unit for $500M, Aveo Stock Climbs, Pfizer Buys FoldRx, & More Boston-Area Life Sciences News	Erin Kutz	09/03/10	Boston
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area	Ryan McBride	09/01/10	Boston
Taligen Collects $10M For Focus on Rare Diseases	Ryan McBride	08/23/10	Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?	Ryan McBride	07/29/10	Boston
How Much Would You Pay for Genzyme?	Ryan McBride	07/26/10	Boston
Genzyme Gets FDA Nod for Pompe Drug	Ryan McBride	05/25/10	Boston
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston	Ryan McBride	04/12/10	Boston
Page 1 of 1

Entry

Author

Date

Location

Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug

Arlene Weintraub

05/23/12

Boston

Pfizer Takes on Genzyme With New Gaucher Drug

Arlene Weintraub

05/02/12

Boston